In addition, we have shown that treatment with plerixafor leads to an increase in surface expression of CXCR7 in ALL [10] and others have demonstrated that activation of CXCR4 leads to increased VLA-4-mediated adhesion of ALL blasts [4]. The gene discussed is ACKR3; the disease is acute lymphoblastic leukemia.